APA

Nozaki K., Sugahara H., Ueda S., Ishikawa J., Fuji S., Masaie H., Tada Y., Karasuno T., Iida M., Mitsui H., Kamae T., Saito N., Moriyama Y., Kawakami M., Kato R., Nakae Y., Kida T., Kosugi S., Nakagawa M., Uchida Y., Azenishi Y., Sakaniwa R., Kitamura T. & Shibayama H. (20210427). Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma. : Leukemia & lymphoma.

Chicago

Nozaki Kenji, Sugahara Hiroyuki, Ueda Shuji, Ishikawa Jun, Fuji Shigeo, Masaie Hiroaki, Tada Yuma, Karasuno Takahiro, Iida Masato, Mitsui Hideki, Kamae Tsuyoshi, Saito Norimitsu, Moriyama Yasuhiro, Kawakami Manabu, Kato Ruri, Nakae Yoshiki, Kida Toru, Kosugi Satoru, Nakagawa Masashi, Uchida Yozo, Azenishi Yasuhiko, Sakaniwa Ryoto, Kitamura Tetsuhisa and Shibayama Hirohiko. 20210427. Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma. : Leukemia & lymphoma.

Harvard

Nozaki K., Sugahara H., Ueda S., Ishikawa J., Fuji S., Masaie H., Tada Y., Karasuno T., Iida M., Mitsui H., Kamae T., Saito N., Moriyama Y., Kawakami M., Kato R., Nakae Y., Kida T., Kosugi S., Nakagawa M., Uchida Y., Azenishi Y., Sakaniwa R., Kitamura T. and Shibayama H. (20210427). Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma. : Leukemia & lymphoma.

MLA

Nozaki Kenji, Sugahara Hiroyuki, Ueda Shuji, Ishikawa Jun, Fuji Shigeo, Masaie Hiroaki, Tada Yuma, Karasuno Takahiro, Iida Masato, Mitsui Hideki, Kamae Tsuyoshi, Saito Norimitsu, Moriyama Yasuhiro, Kawakami Manabu, Kato Ruri, Nakae Yoshiki, Kida Toru, Kosugi Satoru, Nakagawa Masashi, Uchida Yozo, Azenishi Yasuhiko, Sakaniwa Ryoto, Kitamura Tetsuhisa and Shibayama Hirohiko. Pretreatment serum soluble interleukin-2 receptor level predicts survival in patients with newly diagnosed follicular lymphoma. : Leukemia & lymphoma. 20210427.